| Company Name: |
BOC Sciences |
| Tel: |
16314854226; +8616314854226 |
| Email: |
inquiry@bocsci.com |
|
| | AZD-3161 Basic information |
| Product Name: | AZD-3161 | | Synonyms: | AZD-3161
(AZD3161);AZD-3161;3-Pyridinecarboxamide, N-[(3S)-3,4-dihydro-5-(5-methoxy-2-pyrazinyl)-2H-1-benzopyran-3-yl]-6-[(2,2,2-trifluoroethoxy)methyl]- | | CAS: | 1369501-46-1 | | MF: | C23H21F3N4O4 | | MW: | 474.43 | | EINECS: | | | Product Categories: | | | Mol File: | 1369501-46-1.mol |  |
| | AZD-3161 Chemical Properties |
| Boiling point | 633.5±55.0 °C(Predicted) | | density | 1.41±0.1 g/cm3(Predicted) | | pka | 13.08±0.20(Predicted) |
| | AZD-3161 Usage And Synthesis |
| Uses | AZD-3161 is a potent and selective blocker of NaV1.7 channel, with a pIC50 of 7.1. AZD-3161 can be used for the research of neuropathic and inflammatory pain[1][2]. | | Definition | ChEBI: Pavinetant is a member of the class of quinolines that is the amide obtained by formal condensation of the carboxy group of 3-[(methanesulfonyl)amino]-2-phenylquinoline-4-carboxylic acid with the amino group of (1S)-1-phenylpropan-1-amine. A neurokinin-3 receptor antagonist that has been trialled as a potential drug for treatment of schizophrenia and menopausal symptoms. It has a role as a neurokinin-3 receptor antagonist and an antipsychotic agent. It is a member of quinolines, a secondary carboxamide, a sulfonamide and an aromatic amide. | | in vivo | AZD-3161 (16-99 μmol/kg; p.o.) displays a dose dependent antinociceptive effect in the phase 1 of the formalin model of pain in rats[1].
AZD-3161 (3 μmol/kg; i.v.) exhibits long half-life (2.2 h) and Vss (4.2 L/kg)[1].
AZD-3161 (10 μmol/kg; p.o.) exhibits high oral bioavailability (44%), long half-life (4.8 h) and Cmax (0.30 μmol/L)[1]. | | References | [1] Kers I, et, al. Structure and activity relationship in the (S)-N-chroman-3-ylcarboxamide series of voltage-gated sodium channel blockers. Bioorg Med Chem Lett. 2012 Sep 1; 22(17): 5618-24. DOI:10.1016/j.bmcl.2012.06.105
[2] Bagal SK, et, al. Recent progress in sodium channel modulators for pain. Bioorg Med Chem Lett. 2014 Aug 15; 24(16): 3690-9. DOI:10.1016/j.bmcl.2014.06.038 |
| | AZD-3161 Preparation Products And Raw materials |
|